Dr. Francis K. Buadi, MD

Dr. Buadi practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Buadi's NPI, 1770575185, was assigned on August 22, 2005. Dr. Buadi graduated from University of Science and Technology SOM in 1991. Dr. Buadi holds Minnesota license 44923.

Dr. Buadi's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Buadi's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Buadi is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Buadi to 2 more hospitals, 1 clinical lab and 1 hospice, each named with a free account. Dr. Buadi's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buadi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Buadi's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Buadi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Buadi's licenses on file in 4 states: Minnesota, Mississippi, Maryland and Tennessee.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Buadi treats.

CMS data shows 1,916 Medicare services from Dr. Buadi across 9 procedure codes in 2024, for 308 Medicare patients. Medicare paid $54,390 for them.

CMS counts 308 Medicare patients who saw Dr. Buadi in 2024. The largest group is 65 to 74, with 173 patients. 64% of them have high blood pressure, and 56% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buadi's median patient age at 71, with 42% women.

In 2024, Dr. Buadi wrote 513 Medicare Part D claims for 124 patients. 75% of them were for generic drugs. CMS names the drug for 397 of them, across 11 drugs with 11 or more claims each, at $2,093,207 in total drug cost. In 2023, CMS named 297 claims across 10 drugs.

Dr. Buadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buadi as offering telehealth.

Dmand AI links 348 papers to Dr. Buadi, published from 2007 to 2025. 2017 was the busiest year, with 26. The most frequent topics are Multiple Myeloma, Hematopoietic Stem Cell Transplantation and Transplantation, Autologous. Dr. Buadi has published most often in Am J Hematol. Dr. Buadi's most frequent co-authors are Morie A. Gertz, MD, Angela Dispenzieri, MD and Shaji K. Kumar, MD.

CMS Open Payments shows 17 general payments to Dr. Buadi from 3 drug and device companies from 2018 to 2019. Speaker and faculty fees make up the largest share, 60% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $30,709.

Dmand AI lists 4 awards for Dr. Buadi, most recently Fellows Program in 2001.

Dr. Buadi graduated from University of Science and Technology SOM in 1991. Dr. Buadi is a member of ACP, AMA and ASH.

Dr. Buadi is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.